These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 31950731)

  • 1. Methamphetamine-related cardiovascular diseases.
    Schwarzbach V; Lenk K; Laufs U
    ESC Heart Fail; 2020 Apr; 7(2):407-414. PubMed ID: 31950731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Characteristics, Histopathological Features, and Clinical Outcome of Methamphetamine-Associated Cardiomyopathy.
    Schürer S; Klingel K; Sandri M; Majunke N; Besler C; Kandolf R; Lurz P; Luck M; Hertel P; Schuler G; Linke A; Mangner N
    JACC Heart Fail; 2017 Jun; 5(6):435-445. PubMed ID: 28571597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methamphetamine-Associated Cardiomyopathy: Addressing the Clinical Challenges.
    Thoi F; Scherer DJ; Kaye DM; Sanders P; Stokes MB
    Heart Lung Circ; 2022 May; 31(5):616-622. PubMed ID: 35153149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular disease associated with methamphetamine use: a review.
    Tobolski J; Sawyer DB; Song SJ; Afari ME
    Heart Fail Rev; 2022 Nov; 27(6):2059-2065. PubMed ID: 35844009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heart disease, methamphetamine and AIDS.
    Yu Q; Larson DF; Watson RR
    Life Sci; 2003 May; 73(2):129-40. PubMed ID: 12738029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quite a lot of smoke but very limited fire--the use of methamphetamine in Europe.
    Griffiths P; Mravcik V; Lopez D; Klempova D
    Drug Alcohol Rev; 2008 May; 27(3):236-42. PubMed ID: 18368604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Characteristics and Outcome of Methamphetamine-Associated Pulmonary Arterial Hypertension and Dilated Cardiomyopathy.
    Zhao SX; Kwong C; Swaminathan A; Gohil A; Crawford MH
    JACC Heart Fail; 2018 Mar; 6(3):209-218. PubMed ID: 29496022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Methamphetamine Consumption During Pregnancy and its Effects on Neonates].
    Pflügner A; Thome U; Bernhard MK; Vogel M; Bläser A; Nickel P; Kiess W
    Klin Padiatr; 2018 Jan; 230(1):31-38. PubMed ID: 29183092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiomyopathy associated with the smoking of crystal methamphetamine.
    Hong R; Matsuyama E; Nur K
    JAMA; 1991 Mar; 265(9):1152-4. PubMed ID: 1996001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histopathological studies of cardiac lesions after long term administration of methamphetamine in high dosage--Part II.
    Islam MN; Jesmine K; Kong Sn Molh A; Hasnan J
    Leg Med (Tokyo); 2009 Apr; 11 Suppl 1():S147-50. PubMed ID: 19345131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics and Outcomes of Methamphetamine Abuse Among Veterans With Heart Failure.
    Nishimura M; Ma J; Fox S; Toomu A; Mojaver S; Juang DK; Maisel AS; Thomas IC
    Am J Cardiol; 2019 Sep; 124(6):907-911. PubMed ID: 31311659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Cardiac Complications of Methamphetamines.
    Paratz ED; Cunningham NJ; MacIsaac AI
    Heart Lung Circ; 2016 Apr; 25(4):325-32. PubMed ID: 26706652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac complications of adult methamphetamine exposures.
    Hawley LA; Auten JD; Matteucci MJ; Decker L; Hurst N; Beer W; Clark RF
    J Emerg Med; 2013 Dec; 45(6):821-7. PubMed ID: 24054881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is Methamphetamine-Linked Cardiomyopathy an Emerging Epidemic for New Generation?
    Latif A; Ahsan MJ; Lateef N; Kapoor V; Lundgren S; Ahsan MZ; Ahmad S; Mirza M
    Curr Probl Cardiol; 2023 Jan; 48(1):101042. PubMed ID: 34780869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cocaine cardiotoxicity: a review of the pathophysiology, pathology, and treatment options.
    Phillips K; Luk A; Soor GS; Abraham JR; Leong S; Butany J
    Am J Cardiovasc Drugs; 2009; 9(3):177-96. PubMed ID: 19463023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methamphetamine abuse and "meth mouth" in Europe.
    De-Carolis C; Boyd GA; Mancinelli L; Pagano S; Eramo S
    Med Oral Patol Oral Cir Bucal; 2015 Mar; 20(2):e205-10. PubMed ID: 25662544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methamphetamine and cardiovascular pathology: a review of the evidence.
    Kaye S; McKetin R; Duflou J; Darke S
    Addiction; 2007 Aug; 102(8):1204-11. PubMed ID: 17565561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of chronic methamphetamine exposure on heart function in uninfected and retrovirus-infected mice.
    Yu Q; Montes S; Larson DF; Watson RR
    Life Sci; 2002 Jul; 71(8):953-65. PubMed ID: 12084392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methamphetamine use: a comprehensive review of molecular, preclinical and clinical findings.
    Panenka WJ; Procyshyn RM; Lecomte T; MacEwan GW; Flynn SW; Honer WG; Barr AM
    Drug Alcohol Depend; 2013 May; 129(3):167-79. PubMed ID: 23273775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adverse cardiovascular events temporally associated with ma huang, an herbal source of ephedrine.
    Samenuk D; Link MS; Homoud MK; Contreras R; Theoharides TC; Wang PJ; Estes NA
    Mayo Clin Proc; 2002 Jan; 77(1):12-6. PubMed ID: 11795249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.